In this episode, we examine the implications of Microsoft's decision to open source EvoDiff, a cutting-edge AI system for protein generation, and how it could accelerate advancements in biotechnology.
Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: https://AIBox.ai/
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
